The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
Conclusion
131I provided an effective therapeutic modality for well-differentiated thyroid cancer patients with distant metastasis. After a mean of follow-up 10 years, more than 60% of cases resulted in DSM when high accumulated 131I doses were administered.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: ORIGINAL ARTICLES Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Iodine | Nuclear Medicine | Statistics | Study | Taiwan Health | Thyroid | Thyroid Cancer | Thyroidectomy